• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Johnson & Johnson Development Corporation

edit

Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.

Milestones

edit

• 
  Johnson & Johnson Development Corporation invested in Neotract. (9/15/09)
  Posted 9/18/09 at 5:03am
• 
  Johnson & Johnson Development Corporation invested in Neurosearch. (8/17/09)
  Posted 9/28/09 at 2:00am
• 
  Johnson & Johnson Development Corporation invested in CoAxia. (6/24/09)
  Posted 6/24/09 at 7:44am
• 
  Johnson & Johnson Development Corporation invested in Catalyst Biosciences. (12/3/08)
  Posted 6/23/09 at 10:50am
• 
  Johnson & Johnson Development Corporation invested in Biolex Therapeutics. (10/6/08)
  Posted 6/22/09 at 11:58am
• 
  Johnson & Johnson Development Corporation invested in Metabolex. (4/19/07)
  Posted 11/9/09 at 3:58pm

Investments

Videos

Sources

1. Neotract, Inc.: Series B $23.7M (onbiovc.com) [edit]
2. NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV (neurosearch.com) [edit]
3. CoAxia, Inc.: Series D $21.5M (onbiovc.com) [edit]
4. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
5. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
6. Metabolex (Metabolex.com) [edit]